IKIryna Ivanivna Knyazkova

Iryna Ivanivna Knyazkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iryna Ivanivna Knyazkova has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EPIDEMIOLOGY OF HYPERTENSIVE DISEASE DURING ARMED CONFLICT IN A FRONTLINE CITY

    by O.M. Bilovol, I.I. Knyazkova, R.V. Lutsenko, О.A. Lutsenko, A.A. Podpryadova

    The aim of this research is to examine the prevalence and incidence of hypertension and related cardiovascular complications, such as acute myocardial infarction and stroke, among the adult population of Kharkiv during the armed conflict in 2022–2023, and to assess their impact on cardiovascular health. Materials and methods. The study relied on data from the Information and Analytical Center for Medical Statistics, focusing on incidence rates of hypertension, acute myocardial infarction, and stroke among the population of Kharkiv from 2021 to 2023. The analysis was carried out using standardized epidemiological methods and uniform diagnostic criteria. Results. The analysis of hypertension prevalence rates per 100,000 population in Kharkiv for 2022 and 2023 revealed an overall increase of 9.5%, with a 9.9% rise among men and a 9.25% rise among women. Furthermore, the incidence of hypertension (per 100,000 adult population) increased by 25.3% overall during the same period, with a significant 47.4% increase among men and a 13.5% increase among women. The analysis of acute myocardial infarction incidence per 100,000 adult population in Kharkiv for 2022 and 2023 showed an increase of 20.4% in 2023. When comparing data between men and women, it was found that the incidence of acute myocardial infarction (per 100,000 adult population) in Kharkiv increased by 26.7% among men and by 11.8% among women. Similarly, the incidence of stroke per 100,000 adult population increased by 13.9% overall between 2022 and 2023. When analyzing stroke incidence per 100,000 adult population in Kharkiv for 2022 and 2023, an increase of 21.8% was observed among men and 5.6% among women. Thus, under the conditions of armed conflict, the prevalence of arterial hypertension (AH) has increased, with a notably higher rise observed among men. In addition, there has been a marked increase in the incidence of cardiovascular complications, particularly acute myocardial infarction and stroke.


  • Open Access

    THE INFLUENCE OF 2-OXOINDOLINE-3-GLYOXYLIC ACID DERIVATIVES ON THE NEUROPHYSIOLOGICAL REACTIONS OF RATS IN THE “BLACK AND WHITE CHAMBER” TEST

    by O.M. Bilovol, R.V. Lutsenko, I.I. Knyazkova, S.V. Kolisnyk, E.G. Shakina

    The number of patients with an anxiety pathology is constantly growing, which requires the search and development of new remedies for protection. The aim of this research is to establish the presence of anxiolytic activity in derivatives of 2-oxoindolin-3-glyoxylic acid basedon testing animals in the “black-and-white chamber” test. Materials and methods. Experiments were performed on 150 adult male rats. The 2-oxoindoline derivatives were suspended ex tempore (water for injection and Tween-80) and administered to rats at a dose of 12 mg/kg intraperitoneally 1 hour before testing. The control group received a solvent with an emulsifier. Diazepam (2 mg/kg) served as a reference preparation. Behavior was studied in the “black and white chamber” test. Results. Compound 2 significantly reduced the residence time in the light compartment of the chamber. Substance 18 reduced the latent period of the first peek by 1.4 times (p<0.01), significantly increased the number and time of peeking, reduced the latent period of exit by 1.6 times (p<0.001), increased the number of exits and the time spent in the illuminated part of the device and significantly increased the percentage of rats peeking or exiting from the dark compartment and also reduced the number of boluses by 1.9-fold (p<0.001) compared to the control. Substance 2-T only increased the total time of peeking, compound K significantly reduced the number of boluses, and compound 3.85 increased the latent period of the first peek by 1.5 times (p<0.002), substance G increased the number of peeks by 1.7 times ( p<0.05), the time of stay in the light compartment of the camera by 2.5 times (p<0.001) and reduced the number of boluses by 1.3 times compared to the injection control (p<0.05). Conclusion. Administration of the IK compound significantly prolonged the latency of the first peek and exit, as well as significantly reduced the number of boluses compared to the control. 100% of animals peeked into the illuminated compartment of the chamber. Derivatives of 2-oxoindoline with the laboratory codes 18, G, and IК changed the neurophysiological reactions of animals in a similar way to the classic anxiolytic diazepam.

  • Open Access

    THE COURSE OF CHRONIC HEART FAILURE IN PERSONS WITH POST-INFARCTION CARDIOSCLEROSIS AND TYPE 2 DIABETES MELLITUS AND OBESITY ACCORDING TO A NUMBER OF METABOLIC AND HORMONAL INDICATORS

    by Inna Dunaieva, Oleksandr Bilovol, Iryna Knyazkova

    The aim of the study is to investigate the effect of lipid metabolism, biomarkers of fractalkin and clusterin inflammation on the development and progression of chronic heart failure in patients with post-infarction cardiosclerosis, type 2 diabetes and obesity. A retrospective analysis of a comprehensive examination of 67 patients with postinfarction cardiosclerosis with concomitant type 2 diabetes and obesity. All patients were divided into 3 groups depending on the functional class (FC) of CHF: 1 group (n = 22) - patients with CHF II FC; Group 2 (n = 23) - patients with CHF III FC; Group 3 (n = 22) - patients with CHF IV FC. All patients were examined clinically, they were instrumental, biochemical and hormonal examination. With the progression of CHF from FC II to FC III there is a deterioration of lipid metabolism: a significant increase in cholesterol levels by 5.5%, TG - by 15.7%, LDL cholesterol - by 74.4%, VLDL cholesterol - by 15 , 9%, reduction of HDL cholesterol - by 27.6% (p <0,05). An analysis of the fractal equation showing that ailing on CHF is advised by FC; rіven clusterin –decrease. Classical changes in patients with postinfarction cardiosclerosis with CHF and concomitant type 2 diabetes mellitus and obesity , which are the formation of atherogenic lipid metabolism disorders associated with body weight, as well as changes in the latest indicators such as fractalkin and clusterin , indicating the role of these molecules in the progression of CHF.


  • INSTRUMENTAL INDICES ASSOSIATED WITH LEFT VENTRICULAR PREHYPERTROPHY IN YOUNG HEALTHY INDIVIDUALS

    by N. Yu. Osovska, B. V. Sheremeta, N. V. Kuzminova, A. O. Gavriluk, I. I. Knyazkova

    The total of 78 healthy individuals 25.3±0.6 years old were examined. Independent predictors of concentric left ventricular remodeling (prehypertrophy

  • COMPARATIVE ASSESSMENT OF THE EFFICACY OF ADDITIONAL ENDOTHELIAL-PROTECTIVE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE

    by N. V. Kuzminova, V. O. Romanova, V. K. Sierkova, H. V. Lukyantseva, N. Yu. Osovska, I. I. Knyazkova, A. O. Havrylyuk, T. V. Marchak

    To study the efficacy of additional appointment of endothelial-protective therapy, depending on the variant of coronary heart disease (CHD) course, 43

  • STATE OF KIDNEY FUNCTION AND FEATURES OF METABOLIC STATUS CHANGES IN PATIENTS WITH HYPERTENSIVE DISEASE WITH DIFFERENT FORMS OF EXTRASYSTOLS

    by N. V. Kuzminova, A. V. Ivankova, S. E. Lozinsky, I. I. Knyazkova, O. M. Kulchytska, А. О. Gavriluk

    156 patients (65 men and 91 women) of middle age with stage II essential hypertension (EH II) were examined. The main group consisted of 124 of them w


  • NEW POSSIBILITIES OF CORRECTION OF CLINICAL STATUS AND ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS

    by N. V. Kuzminova, V. О. Romanova, V. K. Serkova, О. М. Belovol, І. І. Knyazkova, А. О. Gavriluk

    112 patients with coronary heart disease (CHD) were examined: 76 of them were diagnosed with stable CHD, 36 patients were hospitalized with acute coro


  • Open Access

    Evaluation of the efficiency of Vasonate in patients with comorbid pathology: hypertensive disease and liver steatosis

    by N. V. Kuzminova, O. V. Gribenyk, N. Y. Osovskaya, I. I. Knyazkova

    The aim of this study was to study the clinical efficacy and safety of the preparation of meldonium Vazonat® as part of the complex therapy of patients with stage II hypertension with comorbid non-alcoholic fatty liver disease. There were 72 patients under examined, the average age was (48.4 ± 1.8) years. Depending on the composition of the combined therapy, patients were separated into 2 groups: the main (38 patients) and comparisons (34 patients). Patients of the main group to the basic therapy, which consisted of modern antihypertensive drugs and statins, were supplemented with meldonium Vasonate preparation 1 capsule (250 mg) 2 times a day for 2 months. Patient comparison groups received only basic therapy. All the examinations were conducted before the appointment of therapy and after 2 months. The study showed that the appointment of complex therapy with the addition of the drug of meldonium Vasonate® not only promotes normalization of the level and daily profile of arterial pressure, a decrease in its variability and recovery of the vasomotor function of the endothelium, but also positively affects most of the indices of lipid, carbohydrate and fat metabolism, can to a certain extent inhibit the development of further metabolic disorders and reduce cardiovascular risk. Due to the complex action on various links and general mechanisms of the pathogenesis of arterial hypertension and non-alcoholic fatty liver disease, the use of meldonium Vazonat® allows optimizing the standart basic therapy, restoring the metabolic status, accompanied by good tolerance, improvement in the well-being, activity and mood of patients.

  • Open Access

    Obesity in Menopausal Women

    by O. N. Bilovol, I. I. Knyazkova, V. N. Mishchenko, M. V. Bogun

    Obesity is one of the most important medical and social problems of modern society. This pathology is one of the most common chronic diseases in the world. The review studies pathogenetic mechanisms of obesity during menopause, as well as the participation of sex hormones in fat tissue metabolism. A better understanding of the causes and mechanisms of weight gain during this period of a woman's life suggests that obesity is not inevitable and can be effectively countered by the implementation of the principles of healthy lifestyle, and if necessary, by medicated correction as well.


  • Open Access

    Arterial stiffness as a risk factor for arterial hypertension

    by І. І. Knyazkova, M. V. Bogun, N. V. Kuzmіnova, A. V. Zhadan

    The study of the role of central aortic pressure and vascular rigidity in the patients with arte- rial hypertension is an exciting prospect both from scientific and practical points of view. In the survey presented, the mechanisms of the increased arterial stiffness in the patients with arterial hypertension and the clinical data on the evaluation of the interaction between central aortic pressure and the risk of complications in cardiovascular pathology are considered. The evaluation of central blood pressure offers new challenges and additional opportunities for risk stratification for development of cardiovascular complications in young and middle-aged patients, as well as for the evaluation of the effectiveness of antihypertensive drugs.